{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:03:36Z","timestamp":1790499816106,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11064-020-03153-5","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T06:02:48Z","timestamp":1603432968000},"page":"3059-3075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Chronic Treatment With 5-HT2A Receptor Agonists Affects the Behavior and the BDNF System in Mice"],"prefix":"10.1007","volume":"45","author":[{"given":"Anton S.","family":"Tsybko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana V.","family":"Ilchibaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Filimonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Eremin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina K.","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir S.","family":"Naumenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"3153_CR1","doi-asserted-by":"publisher","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA (2013) Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. https:\/\/doi.org\/10.1371\/journal.pmed.1001547","DOI":"10.1371\/journal.pmed.1001547"},{"key":"3153_CR2","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1017\/S0033291713003243","volume":"44","author":"AJ Baxter","year":"2014","unstructured":"Baxter AJ, Vos T, Scott KM, Ferrari AJ, Whiteford HA (2014) The global burden of anxiety disorders in 2010. Psychol Med 44:2363\u20132374. https:\/\/doi.org\/10.1017\/S0033291713003243","journal-title":"Psychol Med"},{"key":"3153_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"GBD","year":"2016","unstructured":"GBD (2016) Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2","journal-title":"Lancet"},{"key":"3153_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1124\/pr.111.005108","volume":"64","author":"AE Autry","year":"2012","unstructured":"Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64:238\u2013258. https:\/\/doi.org\/10.1124\/pr.111.005108","journal-title":"Pharmacol Rev"},{"key":"3153_CR5","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, Burbach KF, Soltanzadeh Zarandi S, Sood A, Paddy MR, Duim WC, Dennis MY, McAllister AK, Ori-McKenney KM, Gray JA, Olson DE (2018) Psychedelics promote structural and functional neural plasticity. Cell Rep 23:3170\u20133182. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.022","journal-title":"Cell Rep"},{"key":"3153_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/mp.2017.61","volume":"22","author":"E Castr\u00e9n","year":"2017","unstructured":"Castr\u00e9n E, Antila H (2017) Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatry 22:1085\u20131095. https:\/\/doi.org\/10.1038\/mp.2017.61","journal-title":"Mol Psychiatry"},{"key":"3153_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neubiorev.2018.04.001","volume":"90","author":"CRAF Diniz","year":"2018","unstructured":"Diniz CRAF, Casarotto PC, Resstel L, Joca SRL (2018) Beyond good and evil: A putative continuum-sorting hypothesis for the functional role of proBDNF\/BDNF-propeptide\/mBDNF in antidepressant treatment. Neurosci Biobehav Rev 90:70\u201383. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.04.001","journal-title":"Neurosci Biobehav Rev"},{"key":"3153_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478","journal-title":"Pharmacol Rev"},{"key":"3153_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/cpt.557","volume":"101","author":"DE Nichols","year":"2017","unstructured":"Nichols DE, Johnson MW, Nichols CD (2017) Psychedelics as medicines: an emerging new paradigm. Clin Pharmacol Ther 101:209\u2013219. https:\/\/doi.org\/10.1002\/cpt.557","journal-title":"Clin Pharmacol Ther"},{"key":"3153_CR10","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/npp.2017.84","volume":"42","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Goodwin GM (2017) The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology 42:2105\u20132113. https:\/\/doi.org\/10.1038\/npp.2017.84","journal-title":"Neuropsychopharmacology"},{"key":"3153_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","volume":"142","author":"JJH Rucker","year":"2018","unstructured":"Rucker JJH, Iliff J, Nutt DJ (2018) Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology 142:200\u2013218. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.040","journal-title":"Neuropharmacology"},{"key":"3153_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","volume":"31","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Nutt DJ (2017) Serotonin and brain function: a tale of two receptors. J Psychopharmacol 31:1091\u20131120. https:\/\/doi.org\/10.1177\/0269881117725915","journal-title":"J Psychopharmacol"},{"key":"3153_CR13","doi-asserted-by":"crossref","unstructured":"Jaggar M, Vaidya VA (2018) 5-HT2A receptors and BDNF regulation: Implications for psychopathology. In: Guiard BP, Di Giovanni G (eds) 5-HT2A receptors in the central nervous system, The Receptors 32. Humana Press, pp 395\u2013438","DOI":"10.1007\/978-3-319-70474-6_17"},{"key":"3153_CR14","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1074\/jbc.M117.779041","volume":"292","author":"I Moutkine","year":"2017","unstructured":"Moutkine I, Quentin E, Guiard BP, Maroteaux L, Doly S (2017) Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers. J Biol Chem 292:6352\u20136368. https:\/\/doi.org\/10.1074\/jbc.M117.779041","journal-title":"J Biol Chem"},{"key":"3153_CR15","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1021\/jm060656o","volume":"49","author":"TH McLean","year":"2006","unstructured":"McLean TH, Parrish JC, Braden MR, Marona-Lewicka D, Gallardo-Godoy A, Nichols DE (2006) 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists. J Med Chem 49:5794\u20135803. https:\/\/doi.org\/10.1021\/jm060656o","journal-title":"J Med Chem"},{"key":"3153_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuropharm.2017.10.004","volume":"142","author":"G Di Giovanni","year":"2018","unstructured":"Di Giovanni G, De Deurwaerd\u00e8re P (2018) TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-ylmethanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above? Neuropharmacology 142:20\u201329. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.004","journal-title":"Neuropharmacology"},{"key":"3153_CR17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00213-014-3739-3","volume":"232","author":"WE Fantegrossi","year":"2015","unstructured":"Fantegrossi WE, Gray BW, Bailey JM, Smith DA, Hansen M, Kristensen JL (2015) Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl) phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice. Psychopharmacology (Berl) 232:1039\u20131047. https:\/\/doi.org\/10.1007\/s00213-014-3739-3","journal-title":"Psychopharmacology (Berl)"},{"key":"3153_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1124\/jpet.117.239905","volume":"361","author":"AA Jensen","year":"2017","unstructured":"Jensen AA, McCorvy JD, Leth-Petersen S, Bundgaard C, Liebscher G, Kenakin TP, Br\u00e4uner-Osborne H, Kehler J, Kristensen JL (2017) Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor Agonist. J Pharmacol Exp Ther 361:441\u2013453. https:\/\/doi.org\/10.1124\/jpet.117.239905","journal-title":"J Pharmacol Exp Ther"},{"key":"3153_CR19","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1007\/s12035-017-0505-7","volume":"55","author":"RO Costa","year":"2018","unstructured":"Costa RO, Perestrelo T, Almeida RD (2018) PROneurotrophins and CONSequences. Mol Neurobiol 55:2934\u20132951. https:\/\/doi.org\/10.1007\/s12035-017-0505-7","journal-title":"Mol Neurobiol"},{"key":"3153_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/bdi.12151","volume":"16","author":"BN Frey","year":"2014","unstructured":"Frey BN, Dias RS (2014) Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder. Bipolar Disord 16:48\u201357. https:\/\/doi.org\/10.1111\/bdi.12151","journal-title":"Bipolar Disord"},{"key":"3153_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuroscience.2010.04.044","volume":"169","author":"NK Popova","year":"2010","unstructured":"Popova NK, Naumenko VS, Cybko AS, Bazovkina DV (2010) Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior. Neuroscience 169:229\u2013235. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.04.044","journal-title":"Neuroscience"},{"key":"3153_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jneumeth.2008.01.024","volume":"170","author":"AV Kulikov","year":"2008","unstructured":"Kulikov AV, Tikhonova MA, Kulikov VA (2008) Automated measurement of spatial preference in the open field test with transmitted lighting. J Neurosci Methods 170:345\u2013351. https:\/\/doi.org\/10.1016\/j.jneumeth.2008.01.024","journal-title":"J Neurosci Methods"},{"key":"3153_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","volume":"38","author":"K Njung'e","year":"1991","unstructured":"Njung'e K, Handley SL (1991) Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38:63\u201367. https:\/\/doi.org\/10.1016\/0091-3057(91)90590-X","journal-title":"Pharmacol Biochem Behav"},{"key":"3153_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nprot.2006.20","volume":"1","author":"RM Deacon","year":"2006","unstructured":"Deacon RM (2006) Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc 1:122\u2013124. https:\/\/doi.org\/10.1038\/nprot.2006.20","journal-title":"Nat Protoc"},{"key":"3153_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1254\/jjp.90.197","volume":"90","author":"H Takeuchi","year":"2002","unstructured":"Takeuchi H, Yatsugi S, Yamaguchi T (2002) Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model. Jpn J Pharmacol 90:197\u2013200. https:\/\/doi.org\/10.1254\/jjp.90.197","journal-title":"Jpn J Pharmacol"},{"key":"3153_CR26","doi-asserted-by":"publisher","unstructured":"Lazic SE (2015) Analytical strategies for the marble burying test: avoiding impossible predictions and invalid p-values. BMC Res Notes. https:\/\/doi.org\/10.1186\/s13104-015-1062-7","DOI":"10.1186\/s13104-015-1062-7"},{"key":"3153_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bbr.2018.11.013","volume":"359","author":"NV Khotskin","year":"2019","unstructured":"Khotskin NV, Plyusnina AV, Kulikova EA, Bazhenova EY, Fursenko DV, Sorokin IE, Kolotygin I, Mormede P, Terenina EE, Shevelev OB, Kulikov AV (2019) On association of the lethal yellow (AY) mutation in the agouti gene with the alterations in mouse brain and behavior. Behav Brain Res 359:446\u2013456. https:\/\/doi.org\/10.1016\/j.bbr.2018.11.013","journal-title":"Behav Brain Res"},{"key":"3153_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneumeth.2004.06.005","volume":"141","author":"AV Kulikov","year":"2005","unstructured":"Kulikov AV, Naumenko VS, Voronova IP, Tikhonova MA, Popova NK (2005) Quantitative RT-PCR assay of 5-HT1A and 5-HT2A serotonin receptor mRNAs using genomic DNA as an external standard. J Neurosci Methods 141:97\u2013101. https:\/\/doi.org\/10.1016\/j.jneumeth.2004.06.005","journal-title":"J Neurosci Methods"},{"key":"3153_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jneumeth.2008.01.008","volume":"170","author":"VS Naumenko","year":"2008","unstructured":"Naumenko VS, Osipova DV, Kostina EV, Kulikov AV (2008) Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain. J Neurosci Methods 170:197\u2013203. https:\/\/doi.org\/10.1016\/j.jneumeth.2008.01.008","journal-title":"J Neurosci Methods"},{"key":"3153_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1134\/S0026893306010067","volume":"40","author":"VS Naumenko","year":"2006","unstructured":"Naumenko VS, Kulikov AV (2006) Quantitative assay of 5-HT(1A) serotonin receptor gene expression in the brain. Mol Biol (Mosk) 40:37\u201344. https:\/\/doi.org\/10.1134\/S0026893306010067","journal-title":"Mol Biol (Mosk)"},{"key":"3153_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbr.2018.01.034","volume":"343","author":"TV Ilchibaeva","year":"2018","unstructured":"Ilchibaeva TV, Tsybko AS, Kozhemyakina RV, Kondaurova EM, Popova NK, Naumenko VS (2018) Genetically defined fear-induced aggression: Focus on BDNF and its receptors. Behav Brain Res 343:102\u2013110. https:\/\/doi.org\/10.1016\/j.bbr.2018.01.034","journal-title":"Behav Brain Res"},{"key":"3153_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1134\/S0026893312020100","volume":"46","author":"VS Naumenko","year":"2012","unstructured":"Naumenko VS, Tsybko AS, Bazovkina DV, Popova NK (2012) Implication of 5-HT2A receptors in the genetic mechanisms of the brain 5-HT system autoregulation. Mol Biol (Mosk) 46:416\u2013422. https:\/\/doi.org\/10.1134\/S0026893312020100","journal-title":"Mol Biol (Mosk)"},{"key":"3153_CR33","doi-asserted-by":"publisher","unstructured":"Buchborn T, Lyons T, Kn\u00f6pfel T (2018) Tolerance and tachyphylaxis to head twitches induced by the 5-HT2A agonist 25CN-NBOH in mice. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.00017","DOI":"10.3389\/fphar.2018.00017"},{"key":"3153_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1021\/cn300138m","volume":"4","author":"JB Hanks","year":"2013","unstructured":"Hanks JB, Gonz\u00e1lez-Maeso J (2013) Animal models of serotonergic psychedelics. ACS Chem Neurosci 4:33\u201342. https:\/\/doi.org\/10.1021\/cn300138m","journal-title":"ACS Chem Neurosci"},{"key":"3153_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuropharm.2013.01.014","volume":"70","author":"AL Halberstadt","year":"2013","unstructured":"Halberstadt AL, Powell SB, Geyer MA (2013) Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology 70:218\u2013227. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.01.014","journal-title":"Neuropharmacology"},{"key":"3153_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00213-009-1694-1","volume":"212","author":"MA Fox","year":"2010","unstructured":"Fox MA, French HT, LaPorte JL, Blackler AR, Murphy DL (2010) The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis. Psychopharmacology (Berl) 212:13\u201323. https:\/\/doi.org\/10.1007\/s00213-009-1694-1","journal-title":"Psychopharmacology (Berl)"},{"key":"3153_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0014-2999(97)01197-7","volume":"334","author":"F Chaouloff","year":"1997","unstructured":"Chaouloff F, Kulikov A, Morm\u00e8de P (1997) Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors. Eur J Pharmacol 334:25\u201329. https:\/\/doi.org\/10.1016\/s0014-2999(97)01197-7","journal-title":"Eur J Pharmacol"},{"key":"3153_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0163-7258(95)98597-J","volume":"65","author":"G Griebel","year":"1995","unstructured":"Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319\u2013395. https:\/\/doi.org\/10.1016\/0163-7258(95)98597-J","journal-title":"Pharmacol Ther"},{"key":"3153_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuropharm.2003.08.004","volume":"46","author":"EJ Bull","year":"2004","unstructured":"Bull EJ, Hutson PH, Fone KC (2004) Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. Neuropharmacology 46:202\u2013210. https:\/\/doi.org\/10.1016\/j.neuropharm.2003.08.004","journal-title":"Neuropharmacology"},{"key":"3153_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbr.2011.08.044","volume":"226","author":"DC de Paula","year":"2012","unstructured":"de Paula DC, Torricelli AS, Lopreato MR, Nascimento JO, Viana MB (2012) 5-HT(2A) receptor activation in the dorsolateral septum facilitates inhibitory avoidance in the elevated T-maze. Behav Brain Res 226:50\u201355. https:\/\/doi.org\/10.1016\/j.bbr.2011.08.044","journal-title":"Behav Brain Res"},{"key":"3153_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0091-3057(02)00822-5","volume":"73","author":"MF Hawkins","year":"2002","unstructured":"Hawkins MF, Uzelac SM, Baumeister AA, Hearn JK, Broussard JI, Guillot TS (2002) Behavioral responses to stress following central and peripheral injection of the 5-HT(2) agonist DOI. Pharmacol Biochem Behav 73:537\u2013544. https:\/\/doi.org\/10.1016\/S0091-3057(02)00822-5","journal-title":"Pharmacol Biochem Behav"},{"key":"3153_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0166-4328(03)00179-7","volume":"147","author":"BA Nic Dhonnchadha","year":"2003","unstructured":"Nic Dhonnchadha BA, Hasco\u00ebt M, Jolliet P, Bourin M (2003) Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice. Behav Brain Res 147:175\u2013184. https:\/\/doi.org\/10.1016\/S0166-4328(03)00179-7","journal-title":"Behav Brain Res"},{"key":"3153_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbr.2005.07.013","volume":"166","author":"N Ripoll","year":"2006","unstructured":"Ripoll N, Hasco\u00ebt M, Bourin M (2006) Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice. Behav Brain Res 166:131\u2013139. https:\/\/doi.org\/10.1016\/j.bbr.2005.07.013","journal-title":"Behav Brain Res"},{"key":"3153_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbr.2007.11.005","volume":"188","author":"F Masse","year":"2008","unstructured":"Masse F, Petit-Demouliere B, Dubois I, Hasco\u00ebt M, Bourin M (2008) Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test. Behav Brain Res 188:291\u2013297. https:\/\/doi.org\/10.1016\/j.bbr.2007.11.005","journal-title":"Behav Brain Res"},{"key":"3153_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/7854_2016_466","volume":"36","author":"AL Halberstadt","year":"2018","unstructured":"Halberstadt AL, Geyer MA (2018) Effect of Hallucinogens on Unconditioned Behavior. Curr Top Behav Neurosci 36:159\u2013199. https:\/\/doi.org\/10.1007\/7854_2016_466","journal-title":"Curr Top Behav Neurosci"},{"key":"3153_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1476-5381.1991.tb12392.x","volume":"104","author":"K Njung'e","year":"1991","unstructured":"Njung'e K, Handley SL (1991b) Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br J Pharmacol 104:105\u2013112. https:\/\/doi.org\/10.1111\/j.1476-5381.1991.tb12392.x","journal-title":"Br J Pharmacol"},{"key":"3153_CR47","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1271\/bbb.90095","volume":"73","author":"Y Matsushima","year":"2009","unstructured":"Matsushima Y, Shirota O, Kikura-Hanajiri R, Goda Y, Eguchi F (2009) Effects of Psilocybe argentipes on marble-burying behavior in mice. Biosci Biotechnol Biochem 73:1866\u20131868. https:\/\/doi.org\/10.1271\/bbb.90095","journal-title":"Biosci Biotechnol Biochem"},{"key":"3153_CR48","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1248\/bpb.35.376","volume":"35","author":"N Egashira","year":"2012","unstructured":"Egashira N, Okuno R, Shirakawa A, Nagao M, Mishima K, Iwasaki K, Oishi R, Fujiwara M (2012) Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice. Biol Pharm Bull 35:376\u2013379. https:\/\/doi.org\/10.1248\/bpb.35.376","journal-title":"Biol Pharm Bull"},{"key":"3153_CR49","doi-asserted-by":"publisher","unstructured":"Odland AU, Jessen L, Kristensen JL, Fitzpatrick CM, Andreasen JT (2019) The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation. Neuropharmacology 107838. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107838","DOI":"10.1016\/j.neuropharm.2019.107838"},{"key":"3153_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","volume":"204","author":"A Thomas","year":"2009","unstructured":"Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R (2009) Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) 204:361\u2013373. https:\/\/doi.org\/10.1007\/s00213-009-1466-y","journal-title":"Psychopharmacology (Berl)"},{"key":"3153_CR51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fphar.2015.00225","volume":"6","author":"G Zhang","year":"2015","unstructured":"Zhang G, Stackman RW Jr (2015) The role of serotonin 5-HT2A receptors in memory and cognition. Front Pharmacol 6:225. https:\/\/doi.org\/10.3389\/fphar.2015.00225","journal-title":"Front Pharmacol"},{"key":"3153_CR52","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/hipo.22712","volume":"27","author":"G Zhang","year":"2017","unstructured":"Zhang G, Cinalli D, Stackman RW Jr (2017) Effect of a hallucinogenic serotonin 5-HT2A receptor agonist on visually guided, hippocampal-dependent spatial cognition in C57BL\/6J mice. Hippocampus 27:558\u2013569. https:\/\/doi.org\/10.1002\/hipo.22712","journal-title":"Hippocampus"},{"key":"3153_CR53","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/S0028-3908(00)00026-5","volume":"39","author":"A Anji","year":"2000","unstructured":"Anji A, Kumari M, Sullivan Hanley NR, Bryan GL, Hensler JG (2000) Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin. Neuropharmacology 39:1996\u20132005. https:\/\/doi.org\/10.1016\/S0028-3908(00)00026-5","journal-title":"Neuropharmacology"},{"issue":"5","key":"3153_CR54","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.neuropharm.2008.06.001","volume":"55","author":"J Shi","year":"2008","unstructured":"Shi J, Landry M, Carrasco GA, Battaglia G, Muma NA (2008) Sustained treatment with a 5-HT(2A) receptor agonist causes functional desensitization and reductions in agonist-labeled 5-HT(2A) receptors despite increases in receptor protein levels in rats. Neuropharmacology 55(5):687\u2013692. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.06.001","journal-title":"Neuropharmacology"},{"key":"3153_CR55","unstructured":"Raote I, Bhattacharya A, Panicker MM (2007) Serotonin 2A (5-HT2A) receptor function: Ligand-dependent mechanisms and pathways. In: Chattopadhyay A (ed) Serotonin receptors in neurobiology. CRC Press\/Taylor & Francis, pp 105\u2013132"},{"key":"3153_CR56","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1007\/s00213-018-4973-x","volume":"235","author":"S Afshar","year":"2018","unstructured":"Afshar S, Shahidi S, Rohani AH, Komaki A, Asl SS (2018) The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats. Psychopharmacology (Berl) 235:2809\u20132822. https:\/\/doi.org\/10.1007\/s00213-018-4973-x","journal-title":"Psychopharmacology (Berl)"},{"key":"3153_CR57","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","volume":"17","author":"VA Vaidya","year":"1997","unstructured":"Vaidya VA, Marek GJ, Aghajanian GK, Duman RS (1997) 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17:2785\u20132795. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-08-02785.1997","journal-title":"J Neurosci"},{"key":"3153_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(99)00006-3","volume":"262","author":"VA Vaidya","year":"1999","unstructured":"Vaidya VA, Terwilliger RM, Duman RS (1999) Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 262:1\u20134. https:\/\/doi.org\/10.1016\/S0304-3940(99)00006-3","journal-title":"Neurosci Lett"},{"key":"3153_CR59","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neuropharm.2016.04.033","volume":"109","author":"G Zhang","year":"2016","unstructured":"Zhang G, Cinalli D, Cohen SJ, Knapp KD, Rios LM, Mart\u00ednez-Hern\u00e1ndez J, Luj\u00e1n R, Stackman RW Jr (2016) Examination of the hippocampal contribution to serotonin 5-HT2A receptor-mediated facilitation of object memory in C57BL\/6J mice. Neuropharmacology 109:332\u2013340. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.04.033","journal-title":"Neuropharmacology"},{"key":"3153_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mehy.2017.01.013","volume":"100","author":"RD Idell","year":"2011","unstructured":"Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S (2011) The fibrinolytic system: A new target for treatment of depression with psychedelics. Med Hypotheses 100:46\u201353. https:\/\/doi.org\/10.1016\/j.mehy.2017.01.013","journal-title":"Med Hypotheses"},{"key":"3153_CR61","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.yjmcc.2008.12.019","volume":"46","author":"S Yabanoglu","year":"2009","unstructured":"Yabanoglu S, Akkiki M, Seguelas MH, Mialet-Perez J, Parini A, Pizzinat N (2009) Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol 46:518\u2013525. https:\/\/doi.org\/10.1016\/j.yjmcc.2008.12.019","journal-title":"J Mol Cell Cardiol"},{"key":"3153_CR62","doi-asserted-by":"publisher","unstructured":"Kruk JS, Vasefi MS, Heikkila JJ, Beazely MA (2013) Reactive oxygen species are required for 5-HT-induced transactivation of neuronal platelet-derived growth factor and TrkB receptors, but not for ERK1\/2 activation. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0077027","DOI":"10.1371\/journal.pone.0077027"},{"key":"3153_CR63","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1471-4159.2008.05357.x","volume":"106","author":"M Tsuchioka","year":"2008","unstructured":"Tsuchioka M, Takebayashi M, Hisaoka K, Maeda N, Nakata Y (2008) Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells. J Neurochem 106:244\u2013257. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05357.x","journal-title":"J Neurochem"},{"key":"3153_CR64","doi-asserted-by":"publisher","unstructured":"Borroto-Escuela DO, Narv\u00e1ez M, Ambrogini P, Ferraro L, Brito I, Romero-Fernandez W, Andrade-Talavera Y, Flores-Burgess A, Millon C, Gago B, Narvaez JA, Odagaki Y, Palkovits M, Diaz-Cabiale Z, Fuxe K (2018) Receptor-Receptor Interactions in Multiple 5-HT1A Heteroreceptor Complexes in Raphe-Hippocampal 5-HT Transmission and Their Relevance for Depression and Its Treatment. Molecules. https:\/\/doi.org\/10.3390\/molecules23061341","DOI":"10.3390\/molecules23061341"},{"key":"3153_CR65","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.mcn.2007.08.013","volume":"36","author":"X Gao","year":"2007","unstructured":"Gao X, Daugherty RL, Tourtellotte WG (2007) Regulation of low affinity neurotrophin receptor (p75(NTR)) by early growth response (Egr) transcriptional regulators. Mol Cell Neurosci 36:501\u2013514. https:\/\/doi.org\/10.1016\/j.mcn.2007.08.013","journal-title":"Mol Cell Neurosci"},{"key":"3153_CR66","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/(SICI)1097-4652(199806)175:3<341::AID-JCP12>3.0.CO;2-8","volume":"175","author":"M Goppelt-Struebe","year":"1998","unstructured":"Goppelt-Struebe M, Stroebel M (1998) Signaling pathways mediating induction of the early response genes prostaglandin G\/H synthase-2 and egr-1 by serotonin via 5-HT2A receptors. J Cell Physiol 175:341\u2013347. https:\/\/doi.org\/10.1002\/(SICI)1097-4652(199806)175:3<341::AID-JCP12>3.0.CO;2-8","journal-title":"J Cell Physiol"},{"key":"3153_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molbrainres.2005.05.013","volume":"139","author":"K Morita","year":"2005","unstructured":"Morita K, Arimochi H, Her S (2005) Serotonergic 5-HT2A receptor stimulation induces steroid 5alpha-reductase gene expression in rat C6 glioma cells via transcription factor Egr-1. Brain Res Mol Brain Res 139:193\u2013200. https:\/\/doi.org\/10.1016\/j.molbrainres.2005.05.013","journal-title":"Brain Res Mol Brain Res"},{"key":"3153_CR68","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1124\/mol.112.084582","volume":"83","author":"M Kurita","year":"2013","unstructured":"Kurita M, Moreno JL, Holloway T, Kozlenkov A, Mocci G, Garc\u00eda-Bea A, Hanks JB, Neve R, Nestler EJ, Russo SJ, Gonz\u00e1lez-Maeso J (2013) Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice. Mol Pharmacol 83:1166\u20131175. https:\/\/doi.org\/10.1124\/mol.112.084582","journal-title":"Mol Pharmacol"},{"key":"3153_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","volume":"102","author":"C Bj\u00f6rkholm","year":"2016","unstructured":"Bj\u00f6rkholm C, Monteggia LM (2016) BDNF - a key transducer of antidepressant effects. Neuropharmacology 102:72\u201379. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.034","journal-title":"Neuropharmacology"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-020-03153-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T12:48:27Z","timestamp":1606222107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-020-03153-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3153"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03153-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Approval was obtained from the ethics committee of Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of Russian Academy of Sciences.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}